The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative DiseasesSusanne Krasemann, Oleg Butovsky, Vladimir Litvak et al.|Immunity|2017Cited by 3k
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.Ariel Miller, Howard L. Weiner|Proceedings of the National Academy of Sciences|1992Cited by 728
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39Maisa C. Takenaka, Francisco J. Quintana, Galina Gabriely et al.|Nature Neuroscience|2019Cited by 528
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysisLudwig Kappos, Massimo Filippi, David Moeri et al.|The Lancet|1999Cited by 500
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trialFred Lublin, Ludwig Kappos, David H. Miller et al.|The Lancet|2016Cited by 449